AAAAAA

   
Results: 1-21 |
Results: 21
Sarcomatoid renal cell carcinoma: basic biology, clinical behavior and response to therapy
Authors: Chao, D Zisman, A Freedland, SJ Pantuck, AJ Said, JW Belldegrun, AS
Citation: D. Chao et al., Sarcomatoid renal cell carcinoma: basic biology, clinical behavior and response to therapy, UROL ONCOL, 6(6), 2001, pp. 231-238
Analysis of the CHK2 gene in lymphoid malignancies
Authors: Tavor, S Takeuchi, S Tsukasaki, K Miller, CW Hofmann, WK Ikezoe, T Said, JW Koeffler, HP
Citation: S. Tavor et al., Analysis of the CHK2 gene in lymphoid malignancies, LEUK LYMPH, 42(3), 2001, pp. 517-520
Mutations in the mitotic check point gene, MAD1L1, in human cancers
Authors: Tsukasaki, K Miller, CW Greenspun, E Eshaghian, S Kawabata, H Fujimoto, T Tomonaga, M Sawyers, C Said, JW Koeffler, HP
Citation: K. Tsukasaki et al., Mutations in the mitotic check point gene, MAD1L1, in human cancers, ONCOGENE, 20(25), 2001, pp. 3301-3305
Improved prognostication of renal cell carcinoma using an integrated staging system
Authors: Zisman, A Pantuck, AJ Dorey, F Said, JW Shvarts, O Quintana, D Gitlitz, BJ deKernion, JB Figlin, RA Belldegrun, AS
Citation: A. Zisman et al., Improved prognostication of renal cell carcinoma using an integrated staging system, J CL ONCOL, 19(6), 2001, pp. 1649-1657
TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma
Authors: Said, JW Hoyer, KK French, SW Rosenfelt, L Garcia-Lloret, M Koh, PJ Cheng, TC Sulur, GG Pinkus, GS Kuehl, WM Rawlings, DJ Wall, R Teitell, MA
Citation: Jw. Said et al., TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma, LAB INV, 81(4), 2001, pp. 555-564
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. Better correlates with clinicaloutcome
Authors: Zisman, A Pantuck, AJ Chao, D Dorey, F Said, JW Gitlitz, BJ de Kernion, JB Figlin, RA Belldegrun, AS
Citation: A. Zisman et al., Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. Better correlates with clinicaloutcome, J UROL, 166(1), 2001, pp. 54-58
Breast cancer - Cyr61 is overexpressed, estrogen-inducible, and associatedwith more advanced disease
Authors: Xie, D Miller, CW O'Kelly, J Nakachi, K Sakashita, A Said, JW Gornbein, J Koeffler, HP
Citation: D. Xie et al., Breast cancer - Cyr61 is overexpressed, estrogen-inducible, and associatedwith more advanced disease, J BIOL CHEM, 276(17), 2001, pp. 14187-14194
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray
Authors: Hofmann, WK de Vos, S Tsukasaki, K Wachsman, W Pinkus, GS Said, JW Koeffler, HP
Citation: Wk. Hofmann et al., Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray, BLOOD, 98(3), 2001, pp. 787-794
Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: A shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma
Authors: Ma, HJ Sjak-Shie, NN Vescio, RA Kaminsky, M Mikail, A Pold, M Parker, K Beksac, M Belson, D Moss, TJ Wu, CH Zhou, J Zhang, L Chen, G Said, JW Berenson, JR
Citation: Hj. Ma et al., Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: A shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma, CLIN CANC R, 6(11), 2000, pp. 4226-4233
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Authors: Gu, Z Thomas, G Yamashiro, J Shintaku, IP Dorey, F Raitano, A Witte, ON Said, JW Loda, M Reiter, RE
Citation: Z. Gu et al., Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer, ONCOGENE, 19(10), 2000, pp. 1288-1296
PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
Authors: Kubota, T Hisatake, J Hisatake, Y Said, JW Chen, SS Holden, S Taguchi, H Koeffler, HP
Citation: T. Kubota et al., PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo, PROSTATE, 42(3), 2000, pp. 163-171
Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient
Authors: Lones, MA Kirov, I Said, JW Shintaku, IP Neudorf, S
Citation: Ma. Lones et al., Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient, BONE MAR TR, 26(9), 2000, pp. 1021-1024
Co-infection of HHV-6 and HHV-8 is rare in primary effusion lymphoma
Authors: Asou, H Tasaka, T Said, JW Daibata, M Kamada, N Koeffler, HP
Citation: H. Asou et al., Co-infection of HHV-6 and HHV-8 is rare in primary effusion lymphoma, LEUK RES, 24(1), 2000, pp. 59-61
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo
Authors: Kawabata, H Germain, RS Vuong, PT Nakamaki, T Said, JW Koeffler, HP
Citation: H. Kawabata et al., Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo, J BIOL CHEM, 275(22), 2000, pp. 16618-16625
WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma
Authors: Pinthus, JH Waks, T Schindler, DG Harmelin, A Said, JW Belldegrun, A Ramon, J Eshhar, Z
Citation: Jh. Pinthus et al., WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma, CANCER RES, 60(23), 2000, pp. 6563-6567
Novel therapeutic approach: organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo
Authors: Koshiuka, K Elstner, E Williamson, E Said, JW Tada, Y Koeffler, HP
Citation: K. Koshiuka et al., Novel therapeutic approach: organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo, BR J CANC, 82(2), 2000, pp. 452-458
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma
Authors: Widney, D Gundapp, G Said, JW van der Meijden, M Bonavida, B Demidem, A Trevisan, C Taylor, J Detels, R Martinez-Maza, O
Citation: D. Widney et al., Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma, CLIN IMMUNO, 93(2), 1999, pp. 114-123
TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues
Authors: Teitell, M Damore, MA Sulur, GG Stern, MH Said, JW Denny, CT Wall, R
Citation: M. Teitell et al., TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues, P NAS US, 96(17), 1999, pp. 9809-9814
Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia
Authors: Hatta, Y Yamada, Y Tomonaga, M Miyoshi, I Said, JW Koeffler, HP
Citation: Y. Hatta et al., Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia, BLOOD, 93(2), 1999, pp. 613-616
Herpesvirus 8 inclusions in primary effusion lymphoma Report of a unique case with T-cell phenotype
Authors: Said, JW Shintaku, IP Asou, H deVos, S Baker, J Hanson, G Cesarman, E Nador, R Koeffler, HP
Citation: Jw. Said et al., Herpesvirus 8 inclusions in primary effusion lymphoma Report of a unique case with T-cell phenotype, ARCH PATH L, 123(3), 1999, pp. 257-260
Extension of useful reagent shelf life beyond manufacturers' recommendations
Authors: Tubbs, RR Nagle, R Leslie, K Pettigrew, NM Said, JW Corwin, DJ Rickert, RR Roche, PC
Citation: Rr. Tubbs et al., Extension of useful reagent shelf life beyond manufacturers' recommendations, ARCH PATH L, 122(12), 1998, pp. 1051-1052
Risultati: 1-21 |